Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004

The Journal of Urology
Matthew R CooperbergChristopher J Kane

Abstract

The proportion of renal cell carcinoma cases diagnosed at stage I is known to be increasing significantly. We characterized stage I tumors further in terms of tumor size at diagnosis using a large national cancer registry. The National Cancer Data Base captures approximately 75% of all newly diagnosed cancer cases in the United States. The database was queried for all adults who were diagnosed between 1993 and 2004 with stage I renal cell carcinoma. Trends were assessed in mean size with time as well as in the proportion of stage I tumors diagnosed at less than 2.0, less than 2.5 and less than 3.0 cm. There were 104,150 patients in the National Cancer Data Base diagnosed with stage I renal cell carcinoma during the study period. A total of 10,279 stage I tumors (9.9%) were less than 2.0 cm, 26,621 (25.6%) were 2.5 cm or less and 39,879 (38.3%) were 3.0 cm or less. Analysis of stage I renal cell carcinoma diagnoses with time demonstrated a statistically significant increase in the proportion of renal masses 3.0 cm or less between 1993 and 2004 (32.5% vs 43.4%). Of tumors 3.0 cm or less the proportion smaller than 2.0 cm increased significantly during the study period from 24.1% in 1993 to 29.4% in 2004. Mean tumor size decreased...Continue Reading

References

Nov 25, 2003·The Journal of Urology·Igor FrankHorst Zincke
Dec 20, 2005·Urology·Alon Z WeizerThomas J Polascik
Mar 1, 2006·European Urology·Georges-Pascal Haber, Inderbir S Gill
Sep 6, 2006·The Journal of Urology·Bruce SchlomerSam B Bhayani
Sep 21, 2006·Journal of the National Cancer Institute·John M HollingsworthBrent K Hollenbeck
Jan 16, 2007·The Journal of Urology·Sompol PermpongkosolLouis R Kavoussi
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Mar 27, 2013·International Urology and Nephrology·Benjamin WoodsonBenjamin R Lee
Apr 28, 2012·Current Urology Reports·Serge GinzburgAlexander Kutikov
May 19, 2010·Journal of Endourology·Michael J LeveridgeMichael A S Jewett
Mar 6, 2012·Japanese Journal of Clinical Oncology·Sangchul LeeSang Eun Lee
Oct 7, 2008·The Cancer Journal·Wong-Ho Chow, Susan S Devesa
Apr 21, 2012·Advances in Urology·B W LagerveldJ A van der Zee
Dec 4, 2012·Biologics : Targets & Therapy·Marc C SmaldoneElizabeth R Plimack
Oct 14, 2011·Future Oncology·Marc C Smaldone, Robert G Uzzo
Apr 7, 2010·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Ricardo A Rendon
Oct 25, 2012·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Naji J ToumaAnil Kapoor
Apr 11, 2013·Nephro-urology Monthly·Elefterios ChatzidarellisAthanasios G Papatsoris
Feb 22, 2014·Journal of Endourology·M Pilar LagunaUNKNOWN Clinical Research Office of the Endourological Society Renal Mass Study
Jun 30, 2009·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Y RouachA Mejean
Feb 19, 2014·Actas urologicas españolas·F Guerrero-RamosR Díaz-González
Jul 31, 2012·Transplantation Proceedings·M Giessing
Jun 18, 2011·The Journal of Urology·Matthew R CooperbergPeter R Carroll
Jul 19, 2011·Hematology/oncology Clinics of North America·Yuka YamaguchiSteven C Campbell
Nov 11, 2010·Urologic Oncology·Guan Chou Teh
Dec 17, 2009·The Journal of Urology·Robert AbouassalyAntonio Finelli
Dec 17, 2009·The Journal of Urology·Steven L Chang, Mark L Gonzalgo
Feb 3, 2009·European Urology·Jihad H Kaouk, Raj K Goel
Sep 6, 2008·European Urology·Christian Bolenz, Yair Lotan
Mar 25, 2014·BJU International·Jose A KaramSurena F Matin
Nov 7, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Paolo GonteroZiya Kirkali
Sep 8, 2011·BJU International·Véronique PhéMorgan Rouprêt
Sep 21, 2011·BJU International·Robert W RitchieMark E Sullivan
Jul 31, 2013·BJU International·Kaisa L SunelaPirkko-Liisa I Kellokumpu-Lehtinen
Nov 5, 2014·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Ezekiel Maloney, Joo Ha Hwang
Sep 23, 2014·Korean journal of urology·Seung Beom Ha, Cheol Kwak
Apr 18, 2009·The Journal of Urology·K Robin YabroffAlison Martin
Oct 30, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katherine M Krajewski, Ivan Pedrosa
Feb 4, 2009·Current Opinion in Urology·Jennifer A Linehan, Mike M Nguyen
Jul 3, 2009·Current Opinion in Urology·Jean-Jacques Patard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Cancer Institute
John M HollingsworthBrent K Hollenbeck
Current Urology Reports
Kamal Mattar, Michael A S Jewett
The Journal of Urology
Steven C CampbellPractice Guidelines Committee of the American Urological Association
© 2022 Meta ULC. All rights reserved